Overview
Autosomal dominant prognathism, also known as Habsburg jaw or mandibular prognathism, is a hereditary craniofacial condition characterized by excessive forward projection of the lower jaw (mandible) relative to the upper jaw (maxilla). This results in a prominent chin, class III malocclusion (underbite), and facial asymmetry. The condition primarily affects the skeletal and dental systems, leading to difficulties with bite alignment, chewing, speech, and in some cases temporomandibular joint dysfunction. The degree of mandibular protrusion can vary considerably even within the same family, ranging from mild cosmetic concern to significant functional impairment. The condition follows an autosomal dominant inheritance pattern with variable expressivity and incomplete penetrance, meaning that not all individuals who carry the genetic variant will manifest the trait to the same degree. Historically, this condition is famously associated with the European Habsburg royal dynasty, where consanguineous marriages amplified the trait over generations. The genetic basis is thought to be polygenic in many cases, though clear autosomal dominant transmission has been documented in certain families. Specific causative genes have not been definitively established, though several chromosomal loci have been implicated in linkage studies. Treatment depends on the severity of the condition. Mild cases may be managed with orthodontic intervention alone to correct dental alignment. More severe cases typically require orthognathic surgery (corrective jaw surgery) in combination with orthodontics to reposition the mandible and restore proper occlusion and facial balance. Early evaluation by a craniofacial team including orthodontists and oral-maxillofacial surgeons is recommended, particularly during adolescence when jaw growth is nearing completion. Functional outcomes after surgical correction are generally favorable, with improvements in bite function, facial aesthetics, and quality of life.
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Autosomal dominant prognathism.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Autosomal dominant prognathism at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Autosomal dominant prognathism.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Autosomal dominant prognathism.
Community
No community posts yet. Be the first to share your experience with Autosomal dominant prognathism.
Start the conversation →Latest news about Autosomal dominant prognathism
No recent news articles for Autosomal dominant prognathism.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Autosomal dominant prognathism
What is Autosomal dominant prognathism?
Autosomal dominant prognathism, also known as Habsburg jaw or mandibular prognathism, is a hereditary craniofacial condition characterized by excessive forward projection of the lower jaw (mandible) relative to the upper jaw (maxilla). This results in a prominent chin, class III malocclusion (underbite), and facial asymmetry. The condition primarily affects the skeletal and dental systems, leading to difficulties with bite alignment, chewing, speech, and in some cases temporomandibular joint dysfunction. The degree of mandibular protrusion can vary considerably even within the same family, ran
How is Autosomal dominant prognathism inherited?
Autosomal dominant prognathism follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Autosomal dominant prognathism typically begin?
Typical onset of Autosomal dominant prognathism is childhood. Age of onset can vary across affected individuals.